Epigenetics and chromatin structure regulate var2csa expression and the placental binding phenotype in Plasmodium falciparum

  1. Department of Molecular, Cell and Systems Biology, University of California, Riverside, 900 University Avenue, Riverside, CA 92521, USA
  2. Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Tomtebodavägen 16, SE-17165, Solna, Sweden
  3. Department of Cell and Molecular Biology (ICM), Uppsala University, Husargatan 3, SE-75237, Uppsala, Sweden

Editors

  • Reviewing Editor
    Urszula Krzych
    Walter Reed Army Institute of Research, Silver Spring, United States of America
  • Senior Editor
    Dominique Soldati-Favre
    University of Geneva, Geneva, Switzerland

Reviewer #1 (Public Review):

Summary:
The manuscript by Lenz and colleagues describes a detailed examination of the epigenetic changes and alterations in subnuclear arrangement associated with the activation of a unique var gene associated with placental malaria in the human malaria parasite Plasmodium falciparum. The var gene family has been heavily studied over the last couple of decades due to its importance in the pathogenesis of malaria, its role in immune avoidance, and the unique transcriptional regulation that it displays. Aspects of how mutually exclusive expression is regulated have been described by several groups and are now known to include histone modifications, subnuclear chromosomal arrangement, and in the case of var2csa, regulation at the level of translation. Here the authors apply several methods to confirm previous observations and to consider a possible role for DNA methylation. They demonstrate that the histone mark H3K9me3 is found at the promoters of silent genes, var2csa moves away from other var gene clusters when activated, and while DNA methylation is detectable at var genes, it does not seem to correlate with transcriptional activation/silencing. Overall, the data and approach appear sound.

Strengths:
The authors employ the latest methods for epigenetic analysis of histone marks, transcriptomic analysis, DNA methylation, and chromosome conformation. They also use strong selection pressure to be able to examine the gene var2csa in its active and silent state. This is likely the only paper that has used all these methods in parallel to examine var gene regulation. Thus, the paper provides readers with confidence in the interpretation of independent methods that address a similar subject.

Weaknesses:
The primary weakness of the paper is that none of the conclusions are novel and the overall conclusions do not shed much new light on the topic of var gene regulation or antigenic variation in malaria parasites. The paper is largely confirmatory. The roles of H3K9me3 and subnuclear localization in var gene regulation are well established by many groups (including for var2csa), albeit in some cases using alternative methods. The only truly unique aspect of the manuscript is the description of 5mC at var2csa when the gene is transcriptionally active or silent. Here the authors demonstrate that the mark has no clear role in transcriptional activation or silencing, however, this will not be surprising to many in the field who have previously cast doubt on a regulatory role for this modification.

Reviewer #2 (Public Review):

Summary:

Dr Lenz and colleagues report on their in vitro studies comparing gene transcription and epigenetic modifications in Plasmodium falciparum NF54 parasites selected or not selected for adhesion of the infected erythrocytes (IEs) to the placental IE adhesion receptor chondroitin sulfate A (CSA).

The authors report that selection led to preferential transcription of var2csa, the gene that encodes the VAR2CSA-type PfEMP1 well-established as the PfEMP1 mediating IE adhesion to CSA. They confirm that transcriptional activation of var2csa is associated with distinct depletion of H3K9me3 marks and that transcriptional activation is linked to repositioning of var2csa.

Strengths:

The study confirms previously reported features of gene transcription and epigenetic modifications in Plasmodium falciparum.

Weaknesses:

No major new finding is reported.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation